首页> 外文期刊>Journal of Pharmacy and Pharmaceutical Sciences >Development of dissolution tests for the quality control of complementary/alternate and traditional medicines: Application to African potato products
【24h】

Development of dissolution tests for the quality control of complementary/alternate and traditional medicines: Application to African potato products

机译:开发用于辅助/替代和传统药物质量控制的溶出度测试:在非洲马铃薯产品中的应用

获取原文
           

摘要

- Purpose: Unlike orthodox medicines, specific guidelines for dissolution testing of complementary/alternate (CAMs) and traditional medicines (TMs) have not been developed nor is dissolution testing a requirement for the quality control of such products. In this report, the dissolution of African Potato (AP) products, an African traditional medicine (ATM) which has been ingested by man for a diversity of ailments, has been investigated. A norlignan glycoside namely hypoxoside and a sterol, ?-sitosterol (BSS) are purported to be the most important phytochemicals in marketed products of AP. Dissolution testing of AP products containing labelled content of sterols and those containing only hypoxoside is proposed whereby BSS and hypoxoside are monitored as markers for the release of the contents of the abovementioned products, respectively. Methods: The FDA dissolution guidance for industry was used to study the best dissolution condition for several formulations of AP. Buffers in the range of pH 1.2 to 7.5 were used to investigate the dissolution of AP products containing hypoxoside as a marker compound. Similarly, biorelevant dissolution media such as fasted state simulation fluid (FaSSIF) and fed state simulation fluid (FeSSIF) at different pH were used to investigate the release of BSS in AP formulations labelled to contain sterols which exhibited poor water solubility. Results: Dissolution testing of AP products containing hypoxoside, conducted at pH 1.2 using USP Apparatus 1 indicated that more than 75% of hypoxoside was released within 1 hr. Dissolution testing of products containing sterols, conducted in FeSSIF at a pH of 5.0 resulted in a release of at least 75% of BSS after 1 hr for all but one of the products tested. Conclusions: Dissolution testing conditions have been developed for AP products containing two different marker compounds where one of the components, hypoxoside, is water soluble, whereas another component, BSS is poorly water soluble. This necessitated the use of different dissolution media and pHs in order to monitor the respective release of hypoxoside and BSS from AP products. The results of this study indicate the necessity and possibility of developing appropriate dissolution testing procedures for use in the quality control of CAMs/TMs.
机译:-目的:与传统药物不同,补充/替代品(CAMs)和传统药物(TMs)溶出度测试的具体指南尚未制定,溶出度测试不是此类产品质量控制的要求。在本报告中,已经研究了非洲马铃薯(AP)产品(一种非洲传统药物(ATM))的溶出度,该产品已被人类摄取,用于多种疾病。据称,降冰片烷糖苷即次糖苷和固醇,β-谷甾醇(BSS)是AP市售产品中最重要的植物化学物质。提出了对含有固醇标记含量的AP产品和仅含有次糖苷的AP产品进行溶出度测试的方法,其中分别监测BSS和次糖苷作为释放上述产物内容物的标志物。方法:使用FDA的行业溶出度指南研究几种AP制剂的最佳溶出条件。使用pH在1.2至7.5之间的缓冲液来研究含有次氧苷作为标记化合物的AP产品的溶解情况。类似地,使用生物相关的溶出介质,例如在不同pH下的禁食状态模拟液(FaSSIF)和进料状态模拟液(FeSSIF),来研究BSS在标记为含有表现出较差水溶性的固醇的AP制剂中的释放。结果:使用USP仪器1在pH 1.2下对含次糖苷的AP产品进行的溶出度测试表明,在1小时内释放了超过75%的次糖苷。在FeSSIF中于pH值为5.0的条件下,对含有固醇的产品进行溶出度测试,结果发现,除了一种测试产品外,所有其他产品在1小时后至少释放了75%的BSS。结论:已经为含有两种不同标记化合物的AP产品开发了溶出度测试条件,其中一种成分次生糖苷是水溶性的,而另一种成分BSS水溶性差。这就需要使用不同的溶出介质和pH值,以监测次生糖苷和BSS从AP产品中的释放。这项研究的结果表明,开发适当的溶出度测试程序以用于CAM / TM的质量控制的必要性和可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号